Paid Clinical Trials Meridian

Discover 72 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 72

DR-01A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

Recruiting

PHASE1

Sponsor:

Dren Bio

Location:

Meridian ID, Northridge CA, San Antonio TX, West Lafayette INshow 8 more

Code:

NCT06602232

Conditions

Alopecia Areata

Vitiligo

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DR-01

68-Ga-PSMA-11Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

Recruiting

Sponsor:

Telix Pharmaceuticals (Innovations) Pty Limited

Location:

Meridian ID, Springfield OR, Fresno CA, San Antonio TXshow 1 more

Code:

NCT06655064

Conditions

Prostate Cancer (Adenocarcinoma)

Eligibility Criteria

Sex: Male

Age: 21+

Healthy Volunteers: Not accepted

Interventions

None- Observational

mRNA-1083A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age

Recruiting

PHASE2

Sponsor:

Moderna

Location:

Meridian ID, Scottsdale AZ, San Diego CA, Norfolk NEshow 12 more

Code:

NCT06864143

Conditions

Influenza

SARS-CoV-2

Eligibility Criteria

Sex: All

Age: 18 - 64

Healthy Volunteers: Accepted

Interventions

mRNA-1083 Composition 1 Dose A Lot A

mRNA-1083 Composition 1 Dose A Lot B

mRNA-1083 Composition 1 Dose B

mRNA-1083 Composition 1 Dose C

mRNA-1083 Composition 2 Dose A

mRNA COVID-19 VaccinesA Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

Recruiting

PHASE3

Sponsor:

Moderna

Location:

Meridian ID, Aurora CO, Banning CA, Montebello CAshow 37 more

Code:

NCT05436834

Conditions

SARS-CoV-2

Eligibility Criteria

Sex: All

Age: 6 - 5

Healthy Volunteers: Accepted

Interventions

mRNA-1273.214

mRNA-1273.815

REACTA Long-Term Follow-Up Study of Participants Exposed to REACT

Recruiting

Sponsor:

Prokidney

Location:

Meridian ID

Code:

NCT05918523

Conditions

Diabetic Kidney Disease

Chronic Kidney Diseases

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Renal Autologous Cell Therapy (REACT)

MyeloMATCHComparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Meridian ID, Boise ID, Nampa ID, Fruitland IDshow 9 more

Code:

NCT06672146

Conditions

Acute Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Decitabine and Cedazuridine

Enasidenib

TigulixostatTigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

Recruiting

PHASE3

Sponsor:

LG Chem

Location:

Meridian ID, South Ogden UT, Salt Lake City UT, West Jordan UTshow 32 more

Code:

NCT05586958

Conditions

Gout

Hyperuricemia

Gout Flare

Tophi

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Tigulixostat

Placebo

Aurix & Standard CareEffectiveness of Aurix Therapy in Pressure Ulcers

Recruiting

Sponsor:

Nuo Therapeutics

Location:

Meridian ID, Visalia CA, Arcadia CA, Montebello CAshow 15 more

Code:

NCT02352467

Conditions

Pressure Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Aurix

SP-624A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

Recruiting

PHASE2

Sponsor:

Sirtsei Pharmaceuticals, Inc.

Location:

Meridian ID, Portland OR, Everett WA, Lafayette CAshow 40 more

Code:

NCT06254612

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

SP-624

Placebo

GalcanezumabA Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

Recruiting

PHASE3

Sponsor:

Eli Lilly and Company

Location:

Meridian ID, Boise ID, Blackfoot ID, Ammon IDshow 38 more

Code:

NCT03432286

Conditions

Episodic Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo